Apex Unit 2 ANS Flashcards

1
Q

Match each chemical signal with the type of receptor to which it binds.

Acetylcholine at neuromuscular junction ​
Insulin at skeletal muscle
Norepinephrine at vascular smooth muscle

Ion channel
​G-protein coupled receptor ​
Tyrosine kinase linked receptor

A

Acetylcholine at neuromuscular junction ​ + ​ Ion channel
Norepinephrine at vascular smooth muscle ​ + ​ G-protein coupled receptor
Insulin at skeletal muscle ​ + ​ Tyrosine kinase linked receptor

Signal transduction is the process by which a cell converts an extracellular signal into an intracellular response.​

There are 4 categories of signal transduction mechanisms:
Ion channels
G-protein coupled receptors
Enzyme linked receptors
Intracellular receptors

Let’s explore each of these in greater detail.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
All of the following are examples of second messengers EXCEPT:
inositol triphosphate.
glutamate.
cyclic adenosine monophosphate.
calcium.
A

Glutamate

First messengers are extracellular chemicals (neurotransmitters, hormones, or drugs) that stimulate a receptor. Second messengers are intracellular chemicals (usually enzymes) that instruct the cell to do something.

Glutamate is the first messenger for the NMDA receptor.
Calcium, cyclic adenosine monophosphate, and inositol triphosphate are second messengers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
Stimulation of which receptors increases phospholipase C? ​ ​ (Select 2.)
Vasopressin-1
Alpha-1
Muscarinic-2
Beta-1
A

Alpha-1
Vasopressin-1

Alpha-1 and vasopressin-1 stimulation increases phospholipase C.
Beta-1 stimulation increases adenylate cyclase.

Muscarinic-2 receptor decreases adenylate cyclase.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Match each receptor with its physiologic action.

α2 ​
β1 ​
β2 ​
M3 ​

Bronchoconstriction
Increased automaticity
Skeletal muscle vasodilation
Diuresis

A

α2 ​ + ​ Diuresis
β1 ​ + ​ Increased automaticity
β2 ​ + ​ Skeletal muscle vasodilation
M3 ​ + ​ Bronchoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Match each receptor with its physiologic action.

M ​
α1 ​
α2 ​ ​
β2 ​

Mydriasis
Decreased insulin release
​Increased insulin release
​Miosis

A

M ​ + ​ Miosis
α1 ​ + ​ Mydriasis
α2 ​ + ​ Decreased insulin release
β2 ​ + ​ Increased insulin release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
Stimulation of the alpha-2 receptor reduces: ​ ​ (Select 2.)
sympathetic tone.
shivering.
platelet aggregation.
serum glucose.
A

Shivering
Sympathetic tone

Hopefully you already know that alpha-2 receptor stimulation reduces SNS outflow and produces sedation, hypnosis, and analgesia.

In addition to these effects, alpha-2 receptor stimulation also:
Produces an antishivering effect
Depresses level of consciousness
Inhibits insulin release → hyperglycemia (not hypoglycemia)
Promotes (not inhibits) platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
Which enzyme metabolizes cyclic adenosine monophosphate?
Protein kinase A
Phospholipase C
Phosphodiesterase III
Adenylate cyclase
A

Phosphodiesterase III

Adenylate cyclase is an effector that converts ATP to cAMP (the second messenger).

​cAMP activates protein kinase A, which initiates a variety of phosphorylation reactions inside the cell.

​Phosphodiesterase III essentially “turns off” cAMP by metabolizing it to AMP.

We know this is confusing stuff. The explanation on the next page will bring all of this into focus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Select the true statements regarding norepinephrine synthesis and release. ​ ​ (Select 2.)
Tyrosine hydroxylase catalyzes the rate limiting step in norepinephrine synthesis.
The adrenal medulla releases 80% norepinephrine and 20% epinephrine.
Norepinephrine in the synaptic cleft inhibits its release.
Norepinephrine is converted to epinephrine in sympathetic post-ganglionic nerves.

A

Tyrosine hydroxylase catalyzes the rate limiting step in norepinephrine synthesis.

Norepinephrine in the synaptic cleft inhibits its own release.

What was wrong with the other answer choices?

Norepinephrine is converted to epinephrine in the adrenal medulla (not in sympathetic post-ganglionic nerves).
The adrenal medulla releases 80% epinephrine and 20% norepinephrine (the answer choice was reversed).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the PRIMARY mechanism for the termination of action of norepinephrine in the synaptic cleft?

Monoamine oxidase
Diffusion
Catechol-O-methyltransferase
Reuptake

A

Reuptake

Approximately 80% of the NE released into the synaptic cleft undergoes reuptake into the presynaptic neuron. This explains why reuptake is the primary mechanism of NE’s termination of action.

Most of the NE that doesn’t undergo reuptake diffuses into the systemic circulation, where it is subject to metabolism by COMT and MAO in the liver and kidneys. Additionally, a small amount of NE undergoes reuptake into extraneural tissue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
What is the end product of norepinephrine metabolism?
Normetanephrine
Vanillylmandelic acid
Metanephrine
Tyrosine
A

Vanillylmandelic acid

Metabolites of norepinephrine:

Intermediate: ​ metanephrine and normetanephrine
Final end product: ​ vanillylmandelic acid

Tyrosine is a precursor of NE synthesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Select the true statements regarding acetylcholine. ​ (Select 3.)
Hypomagnesemia decreases acetylcholine release from the presynaptic nerve.
It stimulates N-type cholinergic receptors in the sympathetic ganglia.
Pseudocholinesterase hydrolyzes acetylcholine in the synaptic cleft.
Coenzyme A is produced in the mitochondria.
Acetate is a metabolite of acetylcholine metabolism.
Reuptake is the primary mechanism for acetylcholine’s termination of action.

A

Ach stimulates N-type cholinergic receptors in the sympathetic ganglia.
Acetate is a metabolite of acetylcholine metabolism.
​Coenzyme A is produced in the mitochondria.

What was wrong with the other answer choices?

Acetylcholinesterase (not pseudocholinesterase) hydrolyzes acetylcholine in the synaptic cleft.
Hypermagnesemia (not hypomagnesemia) decreases acetylcholine release from the presynaptic nerve.
Metabolism (not reuptake) is the primary mechanism for acetylcholine’s termination of action.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
Preganglionic nerve fibers in the sympathetic nervous system are: ​
myelinated B-fibers.
unmyelinated C-fibers.
myelinated C-fibers.
unmyelinated B-fibers.
A

Myelinated B-fibers

The efferent limb of the ANS reflex arc consists of 2 nerve fibers:

Preganglionic fiber = myelinated B-fiber
Postganglionic fiber = unmyelinated C-fiber

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which statements BEST characterize the architecture of the parasympathetic nervous system? ​ (Select 3.)

Postganglionic fibers release acetylcholine
Myelinated postganglionic fibers
Synapse in the stellate ganglion
Short postganglionic fibers
Post- to preganglionic nerve ratio of 30 : 1
Cell bodies arise from S2 – S4

A

Cell bodies arise from S2-S4
Short postganglionic fibers
Postganglionic fibers release acetylcholine

What was wrong with the other answer choices?
The SNS (not PNS) has a post- to preganglionic nerve ratio of 30:1.
The stellate ganglion is part of the SNS (not PNS).
Autonomic postganglionic fibers are unmyelinated (not myelinated).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Click on the white ramus. ​

A

In the sympathetic nervous system, the preganglionic sympathetic fibers exit the spinal cord via the ventral nerve roots of the spinal nerves. These fibers enter the sympathetic chain by way of the white communicating rami. ​

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
Sympathetic nerves that directly innervate the adrenal medulla are:
B-fibers that release norepinephrine.
B-fibers that release acetylcholine.
C-fibers that release norepinephrine.
C-fibers that release acetylcholine.
A

B-fibers that release acetylcholine

There are no ganglia between the spinal cord and the adrenal medulla. In essence, the adrenal medulla is directly innervated by a “preganglionic” nerve (myelinated B-fiber).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Stimulation of which receptors results in a transcellular potassium shift?

Alpha-1
Alpha-2
Beta-1
Beta-2

A

Beta-2

Stimulation of the beta-2 receptor drives potassium into cells. This explains why drugs like albuterol produce hypokalemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Which surgical procedures are MOST likely to activate the baroreceptor reflex? ​ (Select 2.)

Cesarean section
Carotid endarterectomy
Mediastinoscopy
Strabismus repair

A

Carotid endarterectomy
Mediastinoscopy

Mechanical stimulation of the baroreceptors in the carotid sinus and transverse aortic arch can activate the baroreceptor reflex (bradycardia + hypotension).
Surgical procedures that might elicit this response include:
Carotid endarterectomy / stenting
Mediastinoscopy

There are a variety of other surgical procedures that can predictably activate other cardiovascular reflexes:

Strabismus repair can evoke the oculocardiac reflex.
Cesarean section requires neuraxial blockade to ~ T4. This inhibits the cardioaccelerator nerves (increased vagal tone).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Which drugs are MOST likely to impair the integrity of the baroreceptor reflex. ​ (Select 3.)

Norepinephrine
Hydralazine
Labetalol
Thiopental
Propofol
Sevoflurane
A

Propofol
Sevoflurane
Labetalol

Preservation of the baroreceptor reflex means that the heart rate will adjust appropriately when the blood pressure changes. Hypotension increases the heart rate, while hypertension reduces the heart rate.

Drugs that decrease BP and increase HR (BRR is preserved):
Hydralazine
Thiopental

Drugs that increase BP and decrease HR (BRR is preserved):

Norepinephrine
Drugs that decrease BP and HR (BRR is inhibited):
Labetalol
Sevoflurane

Drugs with variable response (HR can increase, decrease, stay the same, or even stop entirely):
Propofol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
Activation of the Bezold-Jarisch reflex manifests as: ​ (Select 3.)
hypotension.
coronary artery vasoconstriction.
hypertension.
coronary artery vasodilation.
tachycardia.
bradycardia.
A

Bradycardia
Hypotension
Coronary artery vasodilation

The Bezold-Jarisch reflex slows the heart in the setting of profound hypovolemia. The idea is that the heart slows down to allow itself adequate time to fill.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Risk factors that contribute to the manifestation of the oculocardiac reflex include all of the following EXCEPT:

strabismus surgery.
retrobulbar block.
old age.
hypercarbia.

A

Old age

The oculocardiac reflex is otherwise known as the five & dime reflex.

​Afferent limb = CN V (trigeminal nerve)
Efferent limb = CN X (vagus nerve)

The OCR is more likely to occur (or is made worse by) in the following situations:

Traction to the extraocular muscles (particularly the medial rectus)
Pressure on the eye or orbital tissue
Strabismus surgery (particularly in children)
Hypercarbia
Hypoxemia
Light anesthesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Identify the BEST agents to augment the heart rate in the patient with a heart transplant. ​ ​ (Select 2.)

Isoproterenol
Epinephrine
Atropine
Phenylephrine

A

Isoproterenol
Epinephrine

The transplanted heart is severed from autonomic influence, so the heart rate is dependent on the intrinsic rate set by the SA node. Said another way, the transplanted heart is NOT under the influence of the vagus nerve or the cardiac accelerator fibers.

Direct acting agents (isoproterenol and epinephrine) may be used to augment the HR, while indirect acting agents (atropine and ephedrine) will be ineffective.

Phenylephrine can cause reflex bradycardia in the patient with an intact SNS. This would not be expected to occur in the patient with a denervated heart.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Which agent reduces coronary artery perfusion pressure the MOST?

Dopamine
Isoproterenol
Phenylephrine
Dobutamine

A

Isoproterenol

Isoproterenol is a synthetic catecholamine that stimulates beta-1 and beta-2 receptors. ​

Because of its potent beta-2 effect (vasodilation in skeletal muscle), SVR may fall significantly.
This reduces diastolic blood pressure, which can impair coronary perfusion pressure (CPP = AoDB - LVEDP).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q
Which beta blockers antagonize the alpha-1 receptor? ​ (Select 2.)
Atenolol
Carvedilol
Labetalol
Propranolol
A

Labetalol
Carvedilol

Labetalol and carvedilol are mixed alpha and beta antagonists. In addition to their beta effects, these agents produce vasodilation via alpha-1 blockade.

Beta to alpha block ratios:
Labetalol = 7:1
Carvedilol = 10:1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Match each drug with its mechanism of action.
Phenoxybenzamine
Phentolamine
Prazosin ​

A

Phenoxybenzamine ​ + ​ Noncompetative and nonselective alpha antagonist

Phentolamine ​ + ​ Competitive and nonselective alpha antagonist
Prazosin ​ + ​ Competitive and selective alpha-1 antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Put the following signal transduction events in order.

One is the first event and four is the last event

A

1st messenger ​ + ​ 1
G protein ​ + ​ 2
Effector ​ + ​ 3
2nd messenger ​ + ​ 4

Signal transduction describes the process where an extracellular stimulus initiates an intracellular response. We’ll use epinephrine to help us illustrate the big picture. ​
Epinephrine (1st messenger) binds to the beta-1 receptor (g-protein) in the cardiac myocyte membrane. The beta-1 receptor (g-protein) activates an effector enzyme (adenylate cyclase), and this effector enzyme activates the second messenger (cAMP).

​The second messenger (cAMP) initiates a series of phosphorylation reactions that ultimately increase intracellular calcium, leading to a stronger force of contraction. At the same time, these phosphorylation reactions also activate the Ca+2ATPase on the sarcoplasmic reticulum, which improves lusitropy by enhancing calcium uptake back into the sarcoplasmic reticlum. This is how epinephrine simultaneously improves myocardial ​ contractility and relaxation

26
Q

Which of the following enzymes is represented by the blue box?

Guanylate cyclase
Adenylate cyclase
Phosphodiesterase
Phospholipase C

A

Phospholipase C

The image in this question represented the alpha-1 receptor.

​1st messenger: ​ phenylephrine, norepinephrine
Receptor: ​ alpha-1
Effector enzyme: ​ phospholipase C
2nd messenger: ​ IP3, DAG, and Ca+2

Other receptors that behave this way include: ​ vasopressin-1, histamine-1, muscarinic-1, and muscarinic-3.

27
Q

Which enzyme deactivates cAMP?

Phospholipase C
Phosphodiesterase
Protein kinase A
Catechol-o-methyltransferase

A

Phosphodiesterase

Beta-1 receptors are present in the heart and beta-2 receptors are present in the vasculature. Activation of these receptors converts ATP to cAMP inside the cell. cAMP is responsible for turning on a variety of protein kinases that instruct the cell to perform a specific function. Remember that a second messenger’s function is cell specific - it does different things in different cell types. ​

Phosphodiesterase hydrolyzes cAMP to AMP. In essence, this turns off the protein kinases and instructs the cell to stop that specific function. By inhibiting the “turn off” mechanism, phosphodiesterase inhibitors increase cAMP.
In the case of the beta-1 receptor, PDEIs increase intracellular calcium and increase inotropy.
In the case of the beta-2 receptor, PDEIs decrease intracellular calcium and cause vasodilation.

28
Q

Stimulation of which muscarinic receptor inhibits adenylate cyclase?

M1
M2
M3
M5

A

M2

Let’s make this easy. There are 5 subtypes of the muscarinic receptor.

The even numbered muscarinic receptors (2 & 4) inhibit adenylate cyclase.
The odd numbered muscarinic receptors (1, 3 & 5) stimulate phospholipase.

29
Q

Match each enzyme with its primary function in catecholamine synthesis.

A

Tyrosine hydroxylase ​ + ​ converts tyrosine to DOPA

DOPA decarboxylase ​ + ​ converts DOPA to dopamine

Dopamine beta-hydroxylase ​ + ​ converts dopamine to norepinephrine

Phenylethanolamine N-methyltransferase ​ + ​ converts norepinephrine to epinephrine

Tyrosine hydroxylase converts tyrosine to DOPA. This is the rate limiting step in catecholamine synthesis.

DOPA decarboxylase converts DOPA to dopamine.

Dopamine beta-hydroxylase converts dopamine to norepinephrine.

Phenylethanolamine N-methyltransferase converts norepinephrine to epinephrine. Adrenergic nerve terminals do not contain this enzyme, which is why they don’t produce EPI. The adrenal medulla does contain this enzyme, so it is capable of producing EPI. ​

30
Q
Match each receptor with its physiologic action.
Beta-1 
Beta-2 
Muscarinic
Muscarinic
A

Beta-1 ​ + ​ Increased inotropy
Beta-2 ​ + ​ Bronchial relaxation
Muscarinic-2 ​ + ​ Decreased chronotropy
Muscarinic-3 ​ + ​ Bronchial constriction

31
Q

Choose the functions carried out by the alpha-1 receptor. ​ (Select 2.)

Increased insulin release
Detrusor relaxation
Mydriasis
Uterine contraction

A

Mydriasis
Uterine contraction

Alpha-1 stimulation causes mydriasis (pupil dilation) and uterine contraction.

Beta-2 relaxes the detrusor muscle in the bladder
Relaxation allows the bladder to store urine.
Contraction is required for the patient to urinate.

Beta-2 also stimulates the beta cells in the pancreas to release insulin. Beta and beta - that’s easy.

32
Q

Norepinephrine can stimulate its own release by agonizing the:

presynaptic beta-2 receptor.
postsynaptic alpha-1 receptor.
presynaptic alpha-2 receptor.
postsynaptic beta-1 receptor.

A

Presynaptic beta-2 receptor

Norepinephrine can influence its own release by interacting with presynaptic adrenergic receptors.
Presynaptic beta-2 increases NE release (positive feedback)
Presynaptic alpha-2 decreases NE release (negative feedback)

Postsynaptic receptors regulate organ function - not neurotransmitter release.

33
Q

Which of the following MOST accurately describe beta agonist activity? ​ (Select 2.)

Beta-1 and beta-2 agonists increase cAMP.
Beta-2 receptors are more sensitive to norepinephrine than epinephrine.
Beta-1 stimulation reduces serum potassium.
Presynaptic beta-2 receptors accelerate endogenous norepinephrine release.

A

Beta-1 and beta-2 agonists increase cAMP

Presynaptic beta-2 receptors accelerate endogenous norepinephrine release

Beta-1 and -2 agonists turn on adenylate cyclase, which increases cAMP.

​Beta-2 stimulation reduces serum K+ by activating the Na+/K+ pump.

Beta-2 receptors are more sensitive to epinephrine than norepinephrine. Low dose epinephrine causes vasodilation by stimulating beta-2 receptors in skeletal muscle. ​

Stimulation of the presynaptic beta-2 receptor accelerates norepinephrine release from the presynaptic nerve terminal. It has the opposite effect of the presynaptic alpha-2 receptor, which reduces NE release.

34
Q

Where is the GREATEST percentage of exogenously administered norepinephrine metabolized? ​ (Select 2.)

Presynaptic neuron
Kidney
Liver
Synaptic cleft

A

Liver
Kidneys

The key to this question is the word “EXogenous.”

The termination of action of ENdogenous norepinephrine is primarily due to reuptake into the presynaptic neuron. Secondary mechanisms include:

Deamination by MAO in the synaptic cleft.
Diffusion into the bloodstream and degraded by MAO and COMT in the liver and kidney.

When you administer NE EXogenously (through the IV), most of it is metabolized by MAO and COMT in the liver and kidney. This explains why exogenous NE has a longer duration of action when compared to endogenous NE.

35
Q

Which of the following BEST describes the architecture of the sympathetic nervous system? ​ (Select 3.)

The post to preganglionic fiber ratio is 1:1.
Sympathetic ganglia are located near the effector organ.
Preganglionic fibers are long unmyelinated B fibers.
Acetylcholine is the neurotransmitter at the SNS ganglia.
The SNS axons exit the spinal cord via the ventral root.
The cell bodies reside in T1-L3.

A

Acetylcholine is the neurotransmitter at the SNS ganglia.

The cell bodies reside in T1-L3 (thoracolumbar region).

The SNS axons exit the spinal cord via the ventral root.

The SNS cell bodies reside in the thoracolumbar region of the spinal cord (T1-L3).
The preganglionic fibers are short, myelinated B fibers.
The postganglionic fibers are long, unmyelinated C fibers.
SNS ganglia are near the spinal cord (not the effector organ).
Ach is the neurotransmitter at the ganglia for both the SNS and PNS.
In the SNS, the post to preganglionic fiber ratio is 30:1.
In the PNS, the post to preganglionic fiber ratio of 3:1.
The axons of sympathetic fibers exit the spinal cord via the ventral root alongside motor neurons. ​

36
Q

Click on the paravertebral ganglion

A

The paravertebral ganglia are where the pre- and postganglionic fibers in the SNS synapse.

There are 31 paired ganglia, and collectively they make up the sympathetic chain.

37
Q

Which cranial nerve makes up the afferent pathway in the oculocardiac reflex?

CN II
CN III
CN V
CN X

A

CN V

You should remember the oculocardiac reflex as the five and dime reflex (V and X).

CN V (ophthalmic branch of the trigeminal n.) is the afferent limb.
CN X (vagus) is the efferent limb.
38
Q

The Bainbridge reflex is associated with: ​ (Select 2.)

Tachycardia
Decreased preload
Bradycardia
Increased preload

A

Increased preload
Tachycardia

The purpose of the Bainbridge reflex is to reduce venous congestion and improve forward flow through the heart. Increased right atrial pressure stretches baroreceptors in the right heart, and vagal afferents transmit this information to the vasomotor center in the medulla. This reduces PNS tone to the heart, manifesting as an increased heart rate. Stretching of the SA node itself alters its rate of spontaneous depolarization, which also contributes to an increased heart rate.

Don’t confuse the Bainbridge reflex with the Bezold-Jarisch reflex. The BJR causes a paradoxical slowing of the heart rate in response to a profound reduction of venous return - the heart slows to allow adequate time to fill. ​

39
Q

Which cardiovascular reflex is activated by the Valsalva maneuver?

Baroreceptor
Cushing
Chemoreceptor
Celiac

A

Baroreceptor

Forced expiration against a closed glottis is called the Valsalva maneuver. The baroreceptor reflex pathway mediates this response (bradycardia). For completeness, inspiration against a closed glottis is called the Mueller maneuver.

The celiac reflex is initiated by traction to the mesentery or other abdominal organs. This reflex is mediated by the vagus nerve and causes bradycardia and hypotension.

Intracranial hypertension causes the Cushing reflex - hypertension, bradycardia, and irregular respirations. Hypertension is the body’s attempt to restore CPP, bradycardia is from the baroreceptor reflex, and irregular respirations are the result of brainstem compression.

The chemoreceptor reflex is stimulated by hypoxia and hypercarbia. It increases minute ventilation and SNS tone

40
Q
The patient with Shy-Drager syndrome is at risk for all of the following EXCEPT:
premature death.
malignant hypertension.
urinary retention.
cerebral hypoperfusion.
A

Malignant hypertension

Shy-Drager syndrome causes autonomic dysfunction as well as degeneration of the the locus coeruleus, intermediolateral column of the spinal cord (where the cell bodies for the SNS efferent nerves live), and the peripheral autonomic nerves.

S/sx reflect autonomic dysfunction and include orthostatic hypotension, urinary retention, impotence, and bowel dysfunction. Death from cerebral hypoperfusion usually occurs within eight years of the initial diagnosis. ​

Autonomic dysfunction contributes to hemodynamic instability during anesthesia. Hypotension is treated with volume resuscitation and direct acting sympathomimetics. Indirect acting adrenergic agonists (ephedrine) and possibly ketamine can cause an exaggerated hypertensive response.

41
Q
Perioperative risks for the patient undergoing resection of a glomus tumor includes all of the following EXCEPT:
exaggerated hypotension.
venous air embolism.
aspiration of gastric contents.
liver dysfunction.
A

Liver dysfunction

Glomus tumors originate from neural crest cells. They are usually not malignant and tend to grow in the neuroendocrine tissues that lay in close proximity to the carotid artery, aorta, glossopharyngeal nerve, and the middle ear.

Glomus tumors tend to release several vasoactive substances:

Norepinephrine (similar to pheochromocytoma): ​ hypertension
Serotonin and kallikrein (similar to carcinoid tumor): ​ bronchoconstriction, headache, hypertension, flushing, and diarrhea
Histamine or bradykinin: ​ bronchoconstriction and hypotension

These tumors do not release epinephrine, because they lack the enzyme that converts NE to EPI (phenylethanolamine N-methyltransferase). Octreotide can be used to treat carcinoid-like s/sx.
Release of vasoactive substances can lead to exaggerated hyper- or hypotension. Cranial nerve dysfunction (glossopharyngeal, vagus, and hypoglossal) can cause swallowing impairment, aspiration of gastric contents, and airway obstruction. Glomus tumors commonly invade the internal jugular vein, so venous air embolism is a concern.

42
Q

Anesthetic considerations for the patient with pheochromocytoma include:

prazosin before atenolol.
labetalol before phenoxybenzamine.
esmolol before phentolamine.
nicardipine before labetalol.

A

Prazosin before atenolol

Pheochromocytoma is a catecholamine secreting tumor (mostly NE) that usually originates in the chromaffin tissue in the adrenal gland. The classic presentation reflects excessive SNS activation and includes headache, diaphoresis, and tachycardia.

​You must alpha block before you beta block (A comes before B). Commonly used alpha antagonists include:

​Non-selective: ​ phenoxybenzamine and phentolamine
Alpha-1 selective: ​ doxazosin and prazosin

Since NE is a potent alpha-1 agonist, blocking beta-2 mediated skeletal muscle vasodilation ↑’s SVR and BP.
Blocking beta-1 first reduces inotropy and can precipitate CHF in the setting of ↑ SVR.

43
Q

Which drugs increase heart rate the MOST in the patient with a heart transplant? ​ (Select 2.)

Isoproterenol
Atropine
Ephedrine
Epinephrine

A

Isoproterenol
Epinephrine

The transplanted heart is severed from autonomic influence, so the heart rate is determined by the intrinsic rate of phase four depolarization of the SA node (100 - 120 bpm).

Atropine reduces vagal tone by competitively antagonizing the M2 receptor. In the absence of vagal input to the heart, atropine has no effect.

Indirect acting vasopressors, such as ephedrine, partially rely on endogenous catecholamine stores in the postsynaptic sympathetic neurons and are therefore less effective at increasing heart rate.

Only direct acting drugs, such as epinephrine and isoproterenol, should be used to increase heart rate in the patient with the denervated heart.

44
Q
Match each drug to its relative affinity for the arterial alpha-1 receptor.
Norepinephrine 
Dopamine 
Dobutamine 
Isoproterenol
A
Norepinephrine = +++++
Dopamine = +++
Dobutamine = +
Isoproterenol = 0

The term “vasopressor” is a misnomer, as this class of drugs have variable effects on systemic vascular resistance. While alpha-1 agonists produce vasoconstriction, beta-2 agonists dilate blood vessels in skeletal muscle and the skin. Moreover, some drugs have varied affinities for different receptors depending on the doses administered.

Arterial alpha-1 stimulation causes vascular smooth muscle contraction as a result of increased intracellular IP3, DAG, and Ca+2. This increases:
Afterload
Blood pressure (BP = CO x SVR)
Coronary perfusion pressure (CPP = AoDBP - LVEDP)
LVEDV

An often overlooked location of the alpha-1 receptor is in the venous capacitance vessels. The molecular physiology is the same, however the physiologic effect is that blood is shifted towards the central circulation. This increases venous return and consequently preload.

Drug affinity at the vascular alpha-1 receptor:

Norepinephrine ​ = ​ +++++
Phenylephrine ​ = ​ ++++
Epinephrine ​ = ​ 0 ​ --> ++++
Dopamine ​ = ​ 0 ​ --> ​ ++++
Ephedrine ​ = ​ ++
Dobutamine ​ = ​ 0/+
Isoproterenol = 0
45
Q

Hemodynamic effects of high dose norepinephrine include:

increased heart rate.
decreased cardiac output.
decreased myocardial oxygen consumption.
increased splanchnic blood flow.

A

Decreased cardiac output

Norepinephrine is a naturally occurring catecholamine with a dose dependent affinity for a1, a2, and b1 receptors. Therefore, it is important to consider the context of the dose when thinking about its physiologic effects.

Lower doses select for the beta-1 receptor (↑ contractility, HR, CO, and BP).
Higher doses have a strong affinity for the alpha-1 receptor. There is a profound rise in SVR with a decrease in cardiac output. Increased BP activates the baroreceptor reflex and reduces heart rate. BRR activation tends to mask the chronotropic effects of beta-1 agonism. ​
Norepinephrine is an ideal drug for low SVR states like sepsis or post-cardiopulmonary bypass hypotension due to low afterload. Avoid NE in the setting of cardiogenic shock, because it increases afterload and MVO2.

Extravasation of peripherally administered NE can cause tissue necrosis, so you should administer it via a central line. If extravasation occurs at a peripheral site, the area should be injected with phentolamine (2.5 - 10 mg in 10 mL of diluent) to vasodilate the affected region.

A stellate ganglion block on the affected side also counteracts vasoconstriction by increasing blood flow to the extremity.

Key Drug Interactions:
MAO inhibitors ​ → ​ reduced norepinephrine clearance ​ → ​ excessive SNS stimulation
Tricyclic antidepressants ​ → ​ reduced norepinephrine reuptake ​ ​ → ​ excessive SNS stimulation

46
Q

An epinephrine infusion at 0.02 mcg/kg/min will MOST likely: ​ (Select 2.)

increase cardiac output.
decrease stroke volume.
decrease systemic vascular resistance.
increase diastolic blood pressure.

A

Decrease systemic vascular resistance
Increase cardiac output

Like norepinephrine, the dose of epinephrine determines its clinical effects.

Low Dose Epi ​ (0.01 - 0.03 mcg/kg/min):
At low doses, non-selective beta effects predominate. Beta-1 stimulation increases heart rate and contractility, while beta-2 stimulation mediates vasodilation in the skeletal muscle. The net effect is typically an increased cardiac output with a reduction in SVR and possibly a slight reduction in blood pressure. Pulse pressure is increased (wider).
​​
Intermediate Dose Epi ​ (0.03-0.15 mcg/kg/min):
This dose range is characterized by mixed beta and alpha effects. ​

High Dose Epi ​ (> 0.15 mcg/kg/min):
In this dose range, the alpha effects prevail and blood pressure rises. Supraventricular tachyarrhythmias are common, and these limit the usefulness of high dose EPI.

47
Q

Which of the following MOST accurately describes the affinity of dopamine at the adrenergic receptors.

Beta > Dopamine > Alpha
Dopamine > Alpha > Beta
Alpha > Beta > Dopamine
Dopamine > Beta > Alpha

A

Dopamine > Beta > Alpha

Low dose Dopamine - Renal ​ (1-2 mcg/kg/min): ​

This dose range is selective for DA1 (postsynaptic) and DA2 (presynaptic) receptors.
In the kidney, DA2 stimulation inhibits NE release from presynaptic nerve terminals, and this augments the vasodilating effects of the DA1 receptor in the renal vasculature. The net effect is increased renal blood flow and urine output.
Since 25 percent of the cardiac output goes to the kidney and low dose dopamine creates renal vasodilation, blood pressure may decrease. A small reflex tachycardia may be observed as well.
Renal dose dopamine does NOT reduce morbidity or mortality and it does NOT prevent renal failure.
Intermediate Dose Dopamine - Cardiac ​ (2-10 mcg/kg/min):

This range activates beta receptors, which increases contractility, heart rate, and cardiac output. Blood pressure is usually unchanged. This is an ideal dose for CHF.

High Dose Dopamine - Vasopressor ​ (10-20 mcg/kg/min):
In this range, dopamine closely resembles high dose NE; alpha effects overshadow the DA and beta effects.

48
Q

Which of the following statements regarding isoproterenol is true?

It decreases coronary artery perfusion pressure.
It is an appropriate selection for the patient with sepsis.
It has alpha-1 agonist effects.
It has a low risk of arrhythmias.

A

It decreases coronary artery perfusion pressure

Isoproterenol is a synthetic catecholamine derived from dopamine. It selectively stimulates β1 and β2 receptors. ​

​It increases heart rate, contractility, and myocardial oxygen consumption. ​
It decreases SVR. The reduction in SVR can be so severe as to drop diastolic blood pressure, and this can impair coronary perfusion pressure (CPP = AoDB - LVEDP).

Isoproterenol causes severe dysrhythmias and tachycardia. Also, it vasodilates nonessential vascular beds, such as those in the muscle and skin. This characteristic precludes its use in septic shock. ​
Clinical uses of isoproterenol include:

Chemical pacemaker for bradycardia unresponsive to atropine
Heart transplant
Bronchoconstriction
Cor pulmonale

49
Q

Click on dobutamine.

A

A catecholamine contains two key components:

Catechol nucleus (benzene ring with a hydroxyl group in the 3rd and 4th position)
Amine side chain

Catecholamines from smallest to largest:
dopamine –> norepinephrine –> epinephrine –> isoproterenol –> dobutamine.

The synthetic catecholamines (isoproterenol and dobutamine) are larger than the endogenous catecholamines.

Dobutamine is the only one that has two benzene rings.

50
Q

Based on the following data, which of the following drugs would MOST likely improve the patient’s condition?
BP: ​ 70/40 mmHg
HR: ​ 120 bpm
CO: ​ 7 L/min

Epinephrine
Dobutamine
Isoproterenol
Norepinephrine

A

Norepinephrine

These hemodynamic data are consistent with sepsis (↑HR, ↑CO ↓BP). This patient requires a higher SVR, which makes norepinephrine the best answer choice.

​Low dose epi (0.01 - 0.03 mcg/kg/min) favors beta-2 stimulation, which reduces SVR. Even at higher doses, epinephrine continues to stimulate the beta-2 receptor thereby offsetting some of the alpha-1 effect. Beta-1 stimulation is not needed for this patient who already has tachycardia and an adequate cardiac output.

​Dobutamine is a synthetic sympathomimetic amine with potent beta-1 and mild beta-2 agonistic effects - neither of which help this patient.

​Isoproterenol is a non-selective beta agonist. Like low dose epi, isoproterenol reduces SVR. Of the answer choices, this is the worst drug you can administer to this patient. ​

As an aside dopamine would also be an acceptable choice, although arrhythmias are more frequent with dopamine than with norepinephrine.

51
Q
Vasopressin: ​ (Select 2.)
can cause seizures.
stimulates aquaporin synthesis.
increases sodium and water reabsorption.
is secreted by the anterior pituitary gland.
A

Stimulates aquaporin synthesis
Can cause seizures

For the purposes of the NCE, vasopressin and arginine vasopressin are the same thing. It is produced by the hypothalamus and released by the posterior pituitary gland.

Vasopressin restores blood pressure in two ways:​

V1 receptor stimulation causes intense vasoconstriction.
V2 receptor stimulation stimulates the synthesis and insertion of aquaporins into the walls of the collecting ducts. This increases water (but not solute) reabsorption and lowers serum osmolarity. As an aside, aldosterone increases water and sodium reabsorption.
​Overdose can cause hyponatremia and seizures.

52
Q
Which drugs are expected to produce the MOST significant cardiovascular response in the patient with a denervated heart? ​ (Select 2.)
Epinephrine
Atropine
Ephedrine
Glucagon
A

Epinephrine
Glucagon

The denervated heart (transplanted heart) is devoid of ANS innervation from the cardiac accelerator fibers or the vagus nerve. As a result, only direct acting agents (and fluid via the Frank-Starling mechanism) will be able to affect myocardial performance.
Drugs that directly stimulate the SA node increase HR:
Epinephrine
Isoproterenol
Glucagon (increases cAMP independent of beta receptor stimulation)

Drugs that indirectly stimulate the SA node will not increase HR:
Atropine
Glycopyrrolate
Ephedrine

53
Q

Which drug is a selective alpha-2 receptor antagonist?

Yohimbine
Phentolamine
Prazosin
Phenoxybenzamine

A

Yohimbine

Yohimbine
Yohimbine is an herb that increases sympathetic tone by increasing NE release from the presynaptic nerve terminal. It is used to treat orthostatic hypotension. Overdose leads to tachycardia and hypertension.

Phenoxybenzamine
Phenoxybenzamine is a long acting, non-selective, noncompetitive antagonist of the alpha-1 and alpha-2 receptor. It favors the alpha-1 receptor, so it mainly decreases SVR with a reciprocal rise in cardiac output. Its primary role is to manage hypertension in the patient with pheochromocytoma (0.5-1 mg/kg po).
Side effects include: ​ orthostatic hypotension and nasal congestion.

​Prazosin
Prazosin is a selective alpha-1 blocker. It does not impact the NE regulating effect of the presynaptic alpha-2 receptor. When compared to a non-selective alpha antagonist, prazosin is less likely to cause a reflex tachycardia. ​

Phentolamine
Phentolamine is a short acting, non-selective, competitive antagonist of the alpha-1 and alpha-2 receptor.

​When administered into the systemic circulation, its alpha-1 antagonist effects can cause hypotension (vasodilation), while its alpha-2 effects may initiate arrhythmias and tachycardia as a result of continued and unregulated release of norepinephrine onto the SA node.

Clinical uses include treatment of pheochromocytoma; remember to alpha-block before you beta-block. It can also be used during autonomic hyperreflexia. The dose for both is 30-70 mcg/kg IV.

Phentolamine can also be injected into tissue surrounding an infiltrated IV containing a vasoconstrictor (2.5 - 10 mg in 10 mL diluent).

54
Q

Which of the following are the BEST treatments for the patient on lisinopril experiencing vasoplegia? ​ (Select 2.)

Vasopressin
Phenylephrine
Methylene blue
Norepinephrine

A

Vasopressin
Methylene blue

Refractory hypotension is also called vasoplegia. The key here is that hypotension does not respond to conventional therapies including adrenergic agonists, hydration, and reducing depth of anesthesia.

​The body normally maintains blood pressure via 3 mechanisms:

SNS tone
RAAS system
Vasopressin
​
General anesthesia greatly disturbs a variety of sympathetic reflexes that maintain blood pressure, while ACEIs impair the RAAS system. This means that patients on ACEI therapy who receive a general anesthetic are largely dependent on endogenous vasopressin. It should be no surprise that vasopressin is the first line therapy. If additional support is required, methylene blue is the next logical choice.

Treatment
Vasopressin 0.5 – 1 unit IV bolus following by an infusion of 0.03 units/min.
Methylene blue 1 – 2 mg/kg over 10 – 20 min followed by an infusion of 0.25 mg/kg/hr.

Methylene blue inhibits the nitric oxide pathway, which causes widespread vasoconstriction. The dose should not exceed 7 mg/kg.

55
Q

Which drug can increase intraocular pressure in the patient with narrow angle glaucoma?

Pilocarpine
Carbachol
Scopolamine
Glycopyrrolate

A

Scopolamine

Intraocular pressure is normally 10 - 22 mmHg. It is determined by the amount of aqueous humor in the eye, choroidal blood volume, central venous pressure, and extraocular muscle tone. Of these, the volume of aqueous humor is probably the most important.

The ciliary muscle is innervated by the oculomotor nerve (CN III). Stimulation of this nerve leads to mydriasis, which thickens the iris and narrows the iridocorneal angle. This reduces aqueous humor outflow and can increase intraocular pressure, particularly in patients with narrow angle glaucoma.
Two answer choices were cholinergic agonists (pilocarpine and carbochol), and the other two were anticholinergics (scopolamine and glycopyrrolate). You already know that many anticholinergics cause mydriasis, so you have to know what makes each one unique. Scopolamine (like atropine) is a tertiary amine that easily diffuses across the blood brain barrier. This characteristic facilities its entry into the eye leading to mydriasis. Glycopyrrolate does not cross the BBB, so it doesn’t cause mydriasis.

56
Q

Rank each drug according to its ability to increase myocardial oxygen demand.

(One is the most potent and three is the least potent)

A

Atropine ​ + ​ 1
Glycopyrrolate ​ + ​ 2
Scopolamine ​ + ​ 3

Tachycardia increases myocardial oxygen demand while simultaneously reducing myocardial oxygen supply. Since atropine is the most potent chronotrope, it is also the answer choice that is associated with the greatest increase in MVO2.

57
Q

Upon emergence from general anesthesia, a patient is combative with flushed skin and mydriasis. Which of the following drugs are capable of provoking this response? ​ (Select 2.)

Diphenhydramine
Physostigmine
Glycopyrrolate
Promethazine

A

Diphenhydramine
Promethazine

This patient is experiencing central anticholinergic syndrome. CNS signs and symptoms include: ​ sedation, stupor, coma, seizures, restlessness, anxiety, hallucinations, and delirium. Other signs of antimuscarinic intoxication include dry mouth, blurred vision, flushed skin, and fever.

You should be aware of drugs that have anticholinergic properties. Two common ones are diphenhydramine and promethazine. These benefits can be useful in the patient with PONV. Diphenhydramine is also useful for the patient experiencing acute Parkinsonian symptoms.
Central anticholinergic syndrome is treated with physostigmine. What separates this drug from the other commonly used anticholinesterases is that it contains a tertiary amine. This property allows it to easily diffuse through the blood brain barrier.

58
Q

Which of the following drugs is primarily eliminated by the kidney?

Propranolol
Carvedilol
Esmolol
Atenolol

A

Atenolol

Atenolol is the only commonly used beta blocker that depends on the kidneys as its primary route of elimination. It can accumulate in the patient with renal failure.

Esmolol is the only beta blocker that is metabolized by RBC esterases. This accounts for a very short t1/2 of 9 min.

The following drugs depend on the liver as their primary site of elimination: ​ propranolol, metoprolol, labetalol, and carvedilol.

59
Q

Match each beta-blocker to its unique characteristic.

A

Atenolol ​ + ​ Accumulation in renal failure
Esmolol ​ + ​ Metabolized by RBC esterases
Labetalol ​ + ​ Intrinsic sympathomimetic effects
Propranolol ​ + ​ Membrane stabilizing properties

Membrane stabilizing properties is another way of saying that a drug has local anesthetic-like effects. This effect reduces the rate of rise of the cardiac action potential, however this probably only occurs when these drugs reach toxic levels. Examples include propranolol and acebutolol.

Beta blockers that exert a partial agonist effect, while simultaneously blocking other agonists that have a higher affinity for the beta receptor are said to have intrinsic sympathomimetic activity. Examples include: ​ labetalol and pindolol.

Esmolol is the only beta-blocker that is metabolized by RBC esterases.
Atenolol is the only commonly used beta-blocker that undergoes renal elimination. It can accumulate in the patient with renal failure.

60
Q

Which drugs are cardioselective? ​ (Select 3.)

Propranolol
Timolol
Atenolol
Carvedilol
Betaxolol
Acebutolol
A

Acebutolol
Atenolol
Betaxolol

You must know which drugs select for the beta-1 receptor and which bind to the beta-1 and beta-2 receptors.

Beta-1 selective antagonists: ​
atenolol, acebutolol, betaxolol, bisoprolol, esmolol, and metoprolol.

Non-selective beta antagonists: ​
carvedilol, labetalol, nadolol, pindolol, propranolol, and timolol.